Summary
- Current Price
- As of today, RNTX price is $0.87, down -8.47% on
- Current Price All-Time High
- RNTX price is currently -99.72% below its historical high of $309.60 set on
- Market Cap
- RNTX current market cap is $74M, up +105.03% over the past 365 days
- PE Ratio
- RNTX PE ratio is unknown
- Revenue
- RNTX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for RNTX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Rein Therapeutics Inc. |
| Ticker | NASDAQ: RNTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | reintx.com |
| Employees | 11 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.87 | ||
| Price, 1D Change | -8.47% | |
| $74M | ||
| - | ||
| - | ||
| 1.57 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.96 | ||
| EPS, 1Y Change | +44.09% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ALRN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.96 | ||
| EPS Estimate | N/A | -$0.53 |
| EPS Est. Change | N/A | +72.96% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.87 | ||
| Price Target | - | $8.00 |
| Price Tgt. Change | - | +824.86% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.24 | -$3.51 | -56.49% | |
| -$0.96 | -$1.96 | -105.24% | |
| -$0.53 | N/A | +72.96% | |
| -$0.50 | N/A | +74.49% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -47.26% | ||
| -52.99% | ||
| +105.03% | ||
| +785.51% | ||
| 0.00% | ||
| 0.00% | ||
| +44.09% | ||
| +67.44% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $0.87 | ||
| $1.28 | ||
| $1.24 | ||
| $1.34 | ||
| $1.13 | ||
| -$0.08 | ||
| 1.57 | ||
| $0.10 | ||
| 31.07 | ||
| 60.05% | ||
| 91.73% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.96 | ||
| -$1,000.00 | ||
| - | ||
| -$21.93M | ||
| - | ||
| -$49.87M | ||
| - | ||
| -$21.93M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 0.70 | ||
| 0.70 | ||
| - | ||
| - | ||
| -19.43 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -2.21 | ||
| -3.46 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$28.09M | ||
| $3.22M | ||
| $26.39M | ||
| $4.33M | ||
| $9.47M | ||
| $6.18M | ||
| $0.00 | ||
| $0.00 | ||
| $3.98M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $49.87M | ||
| $21.93M | ||
| $1,000.00 | ||
| $0.00 | ||
| $1,000.00 | ||
| $0.00 | ||
| -$712.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$19.36M | ||
| $0.00 | ||
| $9.76M | ||
| $0.00 | ||
| -$19.36M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Brookline Capital | → | |
| HC Wainwright & Co. | ||
| Brookline Capital | → |
Analyst sentiment
Institutional ownership
Screeners with RNTX
FAQ
What is the ticker symbol for Rein Therapeutics Inc.?
The ticker symbol for Rein Therapeutics Inc. is NASDAQ:RNTX
Does Rein Therapeutics Inc. pay dividends?
No, Rein Therapeutics Inc. does not pay dividends
What sector is Rein Therapeutics Inc. in?
Rein Therapeutics Inc. is in the Healthcare sector
What industry is Rein Therapeutics Inc. in?
Rein Therapeutics Inc. is in the Biotechnology industry
What country is Rein Therapeutics Inc. based in?
Rein Therapeutics Inc. is headquartered in United States
When did Rein Therapeutics Inc. go public?
Rein Therapeutics Inc. initial public offering (IPO) was on June 29, 2017
Is Rein Therapeutics Inc. in the S&P 500?
No, Rein Therapeutics Inc. is not included in the S&P 500 index
Is Rein Therapeutics Inc. in the NASDAQ 100?
No, Rein Therapeutics Inc. is not included in the NASDAQ 100 index
Is Rein Therapeutics Inc. in the Dow Jones?
No, Rein Therapeutics Inc. is not included in the Dow Jones index
When was Rein Therapeutics Inc. last earnings report?
Rein Therapeutics Inc.'s most recent earnings report was on November 14, 2025
When does Rein Therapeutics Inc. report earnings?
The date for Rein Therapeutics Inc.'s next earnings report has not been announced yet
Data Sources & References
- RNTX Official Website www.reintx.com
- RNTX Profile on Yahoo Finance finance.yahoo.com/quote/RNTX
- RNTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rntx